HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,274 | +5.0% | 327,450 | +18.2% | 0.48% | +31.5% |
| Q2 2023 | $321,337 | -34.9% | 277,015 | -15.2% | 0.36% | -37.0% |
| Q1 2023 | $493,252 | -26.1% | 326,657 | +22.3% | 0.58% | -29.3% |
| Q4 2022 | $667,570 | -33.9% | 267,028 | +11.6% | 0.81% | -25.9% |
| Q3 2022 | $1,010,000 | +100.0% | 239,346 | +32.2% | 1.10% | +115.1% |
| Q2 2022 | $505,000 | -35.7% | 181,010 | +31.9% | 0.51% | +6.7% |
| Q1 2022 | $785,000 | +42.5% | 137,255 | +127.4% | 0.48% | +94.3% |
| Q4 2021 | $551,000 | -18.4% | 60,358 | -4.3% | 0.25% | +0.4% |
| Q3 2021 | $675,000 | +3.5% | 63,098 | +50.2% | 0.24% | +14.0% |
| Q2 2021 | $652,000 | +82.6% | 42,000 | +90.9% | 0.22% | +55.8% |
| Q1 2021 | $357,000 | -23.4% | 22,000 | 0.0% | 0.14% | -60.9% |
| Q4 2020 | $466,000 | – | 22,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |